Paula Sato

Dr. Paula Sato

Laboratory of Medical Investigation in Immunology (LIM48)
+1
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2013 in Future Microbiology
Verified
Journal Article
Closed access
ABAnamelia Bocca
Anamelia Bocca
AAAndre Amaral
Andre Amaral
MTMarcus Melo Teixeira
Marcus Melo Teixeira
PSPaula Sato
Paula Sato
MSMaria Aparecida Shikanai-Yasuda
Maria Aparecida Shikanai-Yasuda
MFMaria Sueli Soares Felipe
Maria Sueli Soares Felipe
Acquired by inhalation of the thermal dimorphic fungi Paracoccidioides spp. conidia, paracoccidioidomycosis ranges from symptomatic to severe and potentially fatal disseminated disease. The main focus of this review is to highlight clinical aspects of paracoccidioidomycosis and, its pathogens' diversity ecology and particularities. In addition, we present strategies for therapy, including DNA vaccines and nanostructured drugs. Molecular and morphological data supported the split of the Paracoccidioides genus into two species, Paracoccidioides brasiliensis and Paracoccidioides lutzii. An acute form of the disease affects approximately 5% of cases and involves the phagocytic mononuclear system, resulting in progressive lymphadenopathy. The chronic form affects adult men and frequently involves lungs, skin and mucous membranes, lymph nodes, and adrenal glands. The clinical manifestations depend on the ability of the host to control the fungal multiplication and dissemination. The long survival time of the fungus in the host tissues allows it to evade immune responses; therefore, successful treatment often requires long-time therapy. The consensus for treatment must consider the severity of the disease and includes sulfone derivatives, amphotericin B and azoles. Novel strategies for therapy, based on DNA vaccines and nanostructured drugs are also presented and discussed in this review.

5 December 2021 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
VCVivian Caso Coelho
Vivian Caso Coelho
SNSamara D’aJuda Pereira Neves
Samara D’aJuda Pereira Neves
MGMauro Cintra Giudice
Mauro Cintra Giudice
GBGil Benard
Gil Benard
MLMarta Heloisa Lopes
Marta Heloisa Lopes
PSPaula Sato
Paula Sato
Background: Nocardia species are ubiquitous in natural environments and can cause nocardiosis. In the present study, the use of Resazurin salt and Spectrophotometry were proposed as alternative methods to reduce subjectivity in the interpretation of susceptibility results to antimicrobials by the broth microdilution method for Nocardia spp. Results: The susceptibility of Nocardia spp. isolates to Amikacin, Ciprofloxacin, Minocycline and Trimethoprim-Sulfamethoxazole was evaluated by Minimum Inhibitory Concentration (MIC) determinations by the broth microdilution method. To verify cellular growth, the colour-changing dye Resazurin was applied, the Optical Densities were measured on a spectrophotometer, and both were compared to Clinical and Laboratory Standards Institute (CLSI) Gold Standard method (visual MIC determination). Percentages of essential and categorical agreements and interpretative categorical errors were calculated within each method (intra-reading) and between them (inter-reading). The Gold Standard visual reading demonstrated 100% of essential and categorical intra-reading agreements for Amikacin, and there was no error when compared with the alternative methods. For Ciprofloxacin, the comparison between the Gold Standard and the Spectrophotometric reading showed 91.5% of essential agreement. In the categorical intra-reading analysis for Minocycline, there were 88.1 and 91.7% in the Gold Standard and in the Spectrophotometric readings, respectively, and 86.4% of concordance between them. High rates of categorical agreement were also observed on the Trimethoprim-Sulfamethoxazole analyses, with 93.7% for the Gold Standard, 84.9% for the Resazurin readings, and 80.5% between them. Conclusions: The alternative methods with Resazurin and Spectrophotometric readings showed high agreement rates with the Gold Standard.

1 September 2016 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
FCF.M.C. Carvalho
F.M.C. Carvalho
FBF.D. Busser
F.D. Busser
VFVera Lucia Freitas
Vera Lucia Freitas
CFC.R. Furucho
C.R. Furucho
ASA. Sadahiro
A. Sadahiro
MSMaria Aparecida Shikanai-Yasuda
Maria Aparecida Shikanai-Yasuda

22 October 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ASAlexandra Gomes dos Santos
Alexandra Gomes dos Santos
EWElieser Hitoshi Watanabe
Elieser Hitoshi Watanabe
DFDaiane Tomomi Ferreira
Daiane Tomomi Ferreira
JOJamille Oliveira
Jamille Oliveira
ÉNÉrika Shimoda Nakanishi
Érika Shimoda Nakanishi
MSMaria Aparecida Shikanai-Yasuda
Maria Aparecida Shikanai-Yasuda
Background: Chagas disease caused by Trypanosoma cruzi (T. cruzi) affects approximately six million individuals worldwide. Clinical manifestations are expected to occur due to the parasite persistence and host immune response. Herein we investigated potential associations between IL1B, IL6, IL17A, or IL18 polymorphism profiles and cardiomyopathy or T. cruzi parasitemia, as well as the impact of HIV infection on cardiopathy. Methods: Two hundred twenty-six patients and 90 control individuals were analyzed. IL1B rs1143627 T>C, IL6 rs1800795 C>G, IL17A rs2275913 G>A, IL18 rs187238 C>G, and IL18 rs1946518 C>A SNVs were analyzed by real-time PCR and T. cruzi parasitemia by PCR. Results: Our data revealed association between a cytokine gene polymorphism and parasitemia never previously reported. The IL6 rs1800795 CG genotype lowered the risk of positive parasitemia (OR = 0.45, 95% CI 0.24–0.86, P = 0.015). Original findings included associations between IL17A rs2275913 AA and IL18 s1946518 AA genotypes with decreased risk of developing cardiomyopathy (OR = 0.27, 95% CI 0.07–0.97, P = 0.044; and OR = 0.35, 95% CI 0.14–0.87, P = 0.023, respectively). IL18 rs1946518 AA and IL1B rs1143627 TC were associated with reduced risk for cardiomyopathy severity, including NYHA (New York Heart Association) class ≥ 2 (OR = 0.21, 95% CI 0.06–0.68, P = 0.009; and OR = 0.48, 95% CI 0.24–0.95, P = 0.036, respectively) and LVEF (left ventricular ejection fraction) <45% for IL18 rs1946518 AA (OR = 0.22, 95% CI 0.05–0.89, P = 0.034). A novel, unexpected protective effect of HIV infection against development/progression of cardiomyopathy was identified, based on a lower risk of developing cardiopathy (OR = 0.48, 95% CI 0.23–0.96, P = 0.039), NYHA class ≥ 2 (OR = 0.15, 95% CI 0.06–0.39, P < 0.001), and LVEF < 45% (OR = 0.03, 95% CI 0.00–0.25, P = 0.001). Digestive involvement was negatively associated with NYHA ≥ 2 and LVEF < 45% (OR = 0.20, 95% CI 0.09–0.47, P < 0.001; and OR = 0.24, 95% CI 0.09–0.62, P = 0.004, respectively). Conclusions: Our data support a protective role of IL17A AA, IL18 AA, and IL1B TC genotypes against development/progression of cardiomyopathy and a modulatory effect of the IL6 CG genotype on the risk of parasitemia in Chagas disease. Notably, HIV infection was shown to protect against development/progression of cardiopathy, potentially associated with a synergistic effect of HIV and highly active antiretroviral therapy (HAART), attenuating a Th1-mediated response in the myocardium. This proposed hypothesis requires confirmation, however, in larger and more comprehensive future studies.

1 February 2012 in Medical Mycology
Verified
Journal Article
Open access
PDF file
Marjorie Vieira BatistaMarjorie Vieira Batista
Marjorie Vieira Batista
PSPaula Sato
Paula Sato
LPLigia C. Pierrotti
Ligia C. Pierrotti
FPFlavio J. de Paula
Flavio J. de Paula
GFGUSTAVO FERNANDES FERREIRA
GUSTAVO FERNANDES FERREIRA
MSMaria Aparecida Shikanai-Yasuda
Maria Aparecida Shikanai-Yasuda
The increase in solid organ transplantations may soon create a rise in the occurrence of endemic fungal diseases, such as paracoccidioidomycosis, due

31 January 2022 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
ARAna Paula Carvalho Reis
Ana Paula Carvalho Reis
GCGiovanna Azevedo Celestrino
Giovanna Azevedo Celestrino
MIMariana Igoa
Mariana Igoa
TJThais Martins Jesus
Thais Martins Jesus
TFTábata Takahashi França
Tábata Takahashi França
MSMaria da Gloria Sousa
Maria da Gloria Sousa
Neutrophils are the first leukocytes recruited to the site of infection and are thought to be responsible for fungal elimination from the skin such as dermatophytes. Neutrophils are able to secrete reactive oxygen species (ROS) and neutrophil extracellular traps (NETs) that can kill different fungi, including Aspergillus, spp., Candida albicans, and Phialophora verrucosa. However, NET production in response to Trichophyton rubrum, the main etiologic agent of dermatophytosis, has yet to be studied. We demonstrated that human neutrophils produce NETs against different morphotypes of T. rubrum in a dose-dependent manner and NET formation is dependent on ROS production. In addition, ROS production by human neutrophils in response to T. rubrum is dependent on NADPH oxidase, but not on fungal viability. NETs mediated killing of T. rubrum. Collectively, these results demonstrate that T. rubrum was able to trigger the production of NETs, suggesting that these extracellular structures may represent an important innate immune effector mechanism controlling physiological response to T. rubrum infection.